US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Health Care AlphaDEX Fund

134.21

+1.200.91%

Volume:136.31K

Turnover:18.28M

Market Cap:1.16B

PE:- -

High:134.81

Open:133.28

Low:133.28

Close:133.01

52wk High:135.82

52wk Low:104.53

Shares:8.65M

Float Shares:8.65M

Volume Ratio:2.38

T/O Rate:1.58%

Dividend:1.02

Dividend Rate:0.76%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Humana's Q2 Adjusted Earnings, Revenue Rise; Affirms 2026 Adjusted EPS Outlook

MT Newswires Live

Humana : Third Quarter Insurance Segment Benefit Ratio Expected to be Slightly Above 94% - Prepared Remarks

THOMSON REUTERS

Humana Leaves Annual Adjusted Profit Outlook Unchanged, Shares Drop

Humana Beats Quarterly Profit Estimates as Medical Costs Stay in Line

Humana Q2 Adj. EPS $7.61 Beats $7.22 Estimate

Benzinga Earnings

Humana Inc Q2 Adjusted EPS USD 7.61 Vs. IBES Estimate USD 7.22

Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance

THOMSON REUTERS

Humana Inc Q2 Adj Benefit Ratio 9.7%

THOMSON REUTERS

Humana Inc Outlook FY EPS USD 6.52

THOMSON REUTERS

Corrected: Humana Inc Gaap Benefit Ratio 91.2 Percent (Not 'Adj Benefit Ratio 9.7%' )

THOMSON REUTERS

Humana Inc Q2 Revenue USD 40,867 Million

THOMSON REUTERS

Humana Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Benzinga Earnings

Medicare is About to Change a Program That Held Down the Cost of Premiums. Here's What to Know.

Top News Today: Stocks Mixed as Oil Drop Offsets Chip Rout

This is the Ideal Retirement Strategy if You Want to Keep Your Healthcare Costs Down

Humana Inc. Stock Underperforms Monday When Compared to Competitors

This is the Ideal Retirement Strategy if You Want to Keep Your Healthcare Costs Down

Humana Inc. Stock Underperforms Friday When Compared to Competitors

Organon's Vtama Cream for Atopic Dermatitis Showed Improvement in Disease Severity in Clinical Study

MT Newswires Live

Organon to present results from analysis of Phase 3 trials of VTAMA cream

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/FXH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","market":"US","secType":"STK","nameCN":"First Trust Health Care AlphaDEX Fund","latestPrice":134.2149,"timestamp":1788379200000,"preClose":133.01,"halted":0,"volume":136305,"delay":0,"changeRate":0.00905871738967002,"floatShares":8650002,"shares":8650002,"eps":0,"marketStatus":"Pre-Mkt","change":1.2049,"latestTime":"09-03 06:25:16 EDT","open":133.28,"high":134.81,"low":133.28,"amount":18275509.9683,"amplitude":0.011503,"askPrice":154.07,"askSize":100,"bidPrice":115.82,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788442200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":134.2149,"sharesOutstanding":7900002,"nav":133.03,"aum":1150709766.06,"dividendRate":0.007624,"bidAskSpread":0.000962,"postHourTrading":{"tag":"盘后","latestPrice":134.22,"preClose":134.2149,"latestTime":"19:30 EDT","volume":23,"amount":3085.7378,"timestamp":1788391805042,"change":0.0051,"changeRate":0.000038,"amplitude":0},"volumeRatio":2.3841215946489585,"impliedVol":0.1526,"impliedVolPercentile":0.5179},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FXH\",,,,,undefined,":{"symbol":"FXH","floatShares":8650002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.3841215946489585,"shares":8650002,"dividePrice":1.0233,"high":134.81,"amplitude":0.011503,"preClose":133.01,"low":133.28,"week52Low":104.525,"pbRate":"--","week52High":135.8199,"institutionHeld":0,"latestPrice":134.2149,"eps":0,"divideRate":0.007624,"volume":136305,"delay":0,"ttmEps":0,"open":133.28,"prevYearClose":113.8213,"prevWeekClose":133.175,"prevMonthClose":132.89,"prevQuarterClose":122.4,"fiveDayClose":135.09,"twentyDayClose":128.3,"sixtyDayClose":115.8773},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FXH\",params:#limit:5,,,undefined,":[{"date":"2026-06-25","symbol":"FXH","amount":0.1183,"announcedDate":"2026-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FXH","amount":0.1858,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FXH","amount":0.1399,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FXH","amount":0.5821,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"},{"date":"2025-06-26","symbol":"FXH","amount":0.0616,"announcedDate":"2025-06-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-26","defaultRemindTime":1750944600000,"name":"First Trust Health Care AlphaDEX Fund","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-30","payableDate":"2025-06-26","currency":"USD","dateTimestamp":1750910400000,"payDate":"2025-06-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FXH\",market:\"US\",,,undefined,":[{"executeDate":"2022-09-23","recordDate":"2022-09-26","paymentDate":"2022-09-30","value":0.1007,"currency":"USD"},{"executeDate":"2022-12-23","recordDate":"2022-12-27","paymentDate":"2022-12-30","value":0.1214,"currency":"USD"},{"executeDate":"2023-03-24","recordDate":"2023-03-27","paymentDate":"2023-03-31","value":0.0438,"currency":"USD"},{"executeDate":"2023-06-27","recordDate":"2023-06-28","paymentDate":"2023-06-30","value":0.0377,"currency":"USD"},{"executeDate":"2023-09-22","recordDate":"2023-09-25","paymentDate":"2023-09-29","value":0.0332,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FXH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655729866","title":"Humana's Q2 Adjusted Earnings, Revenue Rise; Affirms 2026 Adjusted EPS Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2655729866","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655729866?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:20","pubTimestamp":1785320414,"startTime":"0","endTime":"0","summary":"Humana  reported Q2 adjusted earnings Wednesday of $7.61 per diluted share, up from $6.27 a year earlier.Analysts polled by FactSet expected $7.26.Revenue for the quarter ended June 30 was $40.87 billion, up from $32.39 billion a year earlier.Analysts polled by FactSet expected $40.57 billion.For 2026, the company affirmed adjusted EPS of at least $9. Analysts surveyed by FactSet expect $8.98.Humana shares were down 10% in premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4154","LU0348723411.USD","LU0238689110.USD","LU1983260115.SGD","LU0320765489.SGD","LU0256863811.USD","HUM.AU","LU0208291251.USD","LU1093756325.SGD","SG9999014021.USD","LU0170899867.USD","BK7500","LU0211331839.USD","BK4588","BK4533","LU0266013472.USD","LU0390134368.USD","FXH","SG9999014013.SGD","HUM","SG9999014005.SGD","LU0070302665.USD","BK4585","LU1093756168.USD","IHF","LU0417517546.SGD","BK7093","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655662948","title":"Humana : Third Quarter Insurance Segment Benefit Ratio Expected to be Slightly Above 94% - Prepared Remarks","url":"https://stock-news.laohu8.com/highlight/detail?id=2655662948","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655662948?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:17","pubTimestamp":1785320243,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V0W6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0256863811.USD","BK4154","LU0417517546.SGD","SG9999014021.USD","LU0070302665.USD","FXH","HUM","BK4533","LU1983260115.SGD","LU0211331839.USD","BK4588","BK4566","LU1093756168.USD","LU0266013472.USD","LU0320765489.SGD","BK4585","LU0170899867.USD","LU0238689110.USD","LU1093756325.SGD","SG9999014013.SGD","IHF","LU0208291251.USD","LU0348723411.USD","SG9999014005.SGD","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655866165","title":"Humana Leaves Annual Adjusted Profit Outlook Unchanged, Shares Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2655866165","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655866165?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:12","pubTimestamp":1785319926,"startTime":"0","endTime":"0","summary":"UPDATE 4-Humana leaves annual adjusted profit outlook unchanged, shares dropJuly 29 (Reuters)-HumanaHUM.Nstuck to its annual adjusted profit forecast on Wednesday for a second consecutive quarter, dis","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL4N43V0W1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRUH","UNHG","LU0211326755.USD","LU1791710400.SGD","IE00B2B36J28.USD","UNH","FXH","LU2089284900.SGD","BK4534","HUM","TMED","LU2462591277.SGD","XLV","LU0795875169.SGD","IE0004445239.USD","IHF","LU0310800379.SGD","LU0390134368.USD","IE00BJT1NW94.SGD","LU0496365809.HKD","SG9999014880.SGD","LU0048584097.USD","LU2087625088.SGD","IE00BFXG1179.USD","IE00B19Z3B42.SGD","LU0320765489.SGD","LU1670628061.USD","IXJ","LU1066051225.USD","IE00BJJMRX11.SGD","LU0820562030.AUD","MHIP","JDOC","UNHW","GDOC","FHLC","LU1035773651.USD","VHT","UNHU","RXL","IYH","IE0005OL40V9.USD","LU0342679015.USD","IE00B3T34201.USD","LU1732799900.SGD","HRTS","LU0316494557.USD","LU0965509010.AUD","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655665468","title":"Humana Beats Quarterly Profit Estimates as Medical Costs Stay in Line","url":"https://stock-news.laohu8.com/highlight/detail?id=2655665468","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655665468?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:05","pubTimestamp":1785319500,"startTime":"0","endTime":"0","summary":"Humana beats quarterly profit estimates as medical costs stay in lineJuly 29 -HumanaHUM.Non Wednesday beat Wall Street estimates for second-quarter profit as the health insurer's spend on medical services was in line with expectations.On an adjusted basis, the company earned a profit of $7.61 per share, compared with analysts' estimates of $7.22 per share, according to data compiled by LSEG.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nL4N43V0VH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","BK4588","FXH","LU1093756168.USD","LU0320765489.SGD","LU1983260115.SGD","LU0070302665.USD","LU0256863811.USD","SG9999014013.SGD","LU0348723411.USD","LU1093756325.SGD","LU0208291251.USD","SG9999014021.USD","LU0238689110.USD","SG9999014005.SGD","BK4566","LU0211331839.USD","LU0417517546.SGD","LU0170899867.USD","BK4533","IHF","LU0390134368.USD","HUM","LU0266013472.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655866399","title":"Humana Q2 Adj. EPS $7.61 Beats $7.22 Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2655866399","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655866399?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:02","pubTimestamp":1785319320,"startTime":"0","endTime":"0","summary":"Humana Q2 Adj. EPS $7.61 Beats $7.22 Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/HUM","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0170899867.USD","LU0266013472.USD","SG9999014013.SGD","SG9999014005.SGD","LU1983260115.SGD","HUM","LU1093756325.SGD","LU0417517546.SGD","LU0320765489.SGD","LU0348723411.USD","LU0070302665.USD","LU0390134368.USD","LU1093756168.USD","BK4588","LU0238689110.USD","SG9999014021.USD","BK4585","BK4154","LU0256863811.USD","FXH","IHF","LU0211331839.USD","LU0208291251.USD","BK4533","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655866836","title":"Humana Inc Q2 Adjusted EPS USD 7.61 Vs. IBES Estimate USD 7.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2655866836","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655866836?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:01","pubTimestamp":1785319261,"startTime":"0","endTime":"0","summary":"BRIEF-Humana Inc Q2 Adjusted EPS USD 7.61 Vs. IBES Estimate USD 7.22Jul 29 (Reuters) - Humana Inc outlook FY EPS USD 6.52.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nPLXH7ND61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0238689110.USD","LU0348723411.USD","LU1093756325.SGD","SG9999014005.SGD","IHF","LU0417517546.SGD","LU0170899867.USD","HUM","LU0070302665.USD","BK4585","BK4588","LU0208291251.USD","SG9999014013.SGD","LU1093756168.USD","FXH","LU0390134368.USD","LU0211331839.USD","BK4154","BK4566","SG9999014021.USD","LU0266013472.USD","LU0320765489.SGD","BK4533","LU0256863811.USD","LU1983260115.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655886508","title":"Humana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2655886508","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655886508?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:00","pubTimestamp":1785319202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA9DSPVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0170899867.USD","LU0266013472.USD","SG9999014013.SGD","SG9999014005.SGD","LU1983260115.SGD","HUM","LU1093756325.SGD","LU0417517546.SGD","LU0320765489.SGD","LU0348723411.USD","LU0070302665.USD","LU0390134368.USD","LU1093756168.USD","BK4588","LU0238689110.USD","SG9999014021.USD","BK4585","BK4154","LU0256863811.USD","FXH","IHF","LU0211331839.USD","LU0208291251.USD","BK4533","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655986655","title":"Humana Inc Q2 Adj Benefit Ratio 9.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655986655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655986655?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:00","pubTimestamp":1785319201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nPLXH7ND61:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0390134368.USD","LU0211331839.USD","BK4588","LU0070302665.USD","FXH","LU1983260115.SGD","SG9999014005.SGD","LU0320765489.SGD","LU0266013472.USD","IHF","LU0238689110.USD","LU1093756325.SGD","BK4566","LU1093756168.USD","LU0417517546.SGD","BK4533","BK4585","HUM","SG9999014013.SGD","LU0256863811.USD","BK4154","SG9999014021.USD","LU0170899867.USD","LU0208291251.USD","LU0348723411.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655865770","title":"Humana Inc Outlook FY EPS USD 6.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2655865770","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655865770?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:00","pubTimestamp":1785319201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nPLXH7ND61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4566","LU0070302665.USD","BK4154","BK4533","LU1093756325.SGD","HUM","FXH","LU0320765489.SGD","SG9999014005.SGD","SG9999014013.SGD","LU1983260115.SGD","LU0238689110.USD","LU0266013472.USD","LU0208291251.USD","BK4585","LU0348723411.USD","LU0256863811.USD","LU1093756168.USD","IHF","BK4588","LU0390134368.USD","LU0211331839.USD","SG9999014021.USD","LU0170899867.USD","LU0417517546.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655409866","title":"Corrected: Humana Inc Gaap Benefit Ratio 91.2 Percent (Not 'Adj Benefit Ratio 9.7%' )","url":"https://stock-news.laohu8.com/highlight/detail?id=2655409866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655409866?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:00","pubTimestamp":1785319201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nPLXH7ND61:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0070302665.USD","LU0320765489.SGD","LU0390134368.USD","BK4154","LU1093756325.SGD","HUM","IHF","LU0348723411.USD","SG9999014021.USD","BK4585","SG9999014005.SGD","LU0417517546.SGD","BK4533","SG9999014013.SGD","BK4588","LU1983260115.SGD","LU1093756168.USD","BK4566","LU0170899867.USD","LU0211331839.USD","FXH","LU0256863811.USD","LU0238689110.USD","LU0266013472.USD","LU0208291251.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655312866","title":"Humana Inc Q2 Revenue USD 40,867 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2655312866","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655312866?lang=en_us&edition=fundamental","pubTime":"2026-07-29 18:00","pubTimestamp":1785319201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nPLXH7ND61:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999014005.SGD","LU0070302665.USD","LU1983260115.SGD","SG9999014021.USD","LU0320765489.SGD","LU0348723411.USD","LU1093756325.SGD","LU0417517546.SGD","BK4154","BK4588","BK4585","FXH","LU0256863811.USD","BK4566","HUM","SG9999014013.SGD","LU0170899867.USD","LU0266013472.USD","BK4533","IHF","LU0390134368.USD","LU0211331839.USD","LU1093756168.USD","LU0208291251.USD","LU0238689110.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655854823","title":"Humana Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2655854823","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655854823?lang=en_us&edition=fundamental","pubTime":"2026-07-29 14:44","pubTimestamp":1785307482,"startTime":"0","endTime":"0","summary":"Humana (HUM) will release Q2 earnings on July 29. Analysts expect $7 EPS and $40.57B revenue. Recent deals and ratings show potential. #HUM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/07/60749826/humana-gears-up-for-q2-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","BK4566","BK4533","SG9999014021.USD","LU0238689110.USD","LU0320765489.SGD","LU1093756325.SGD","LU0208291251.USD","IHF","LU0070302665.USD","LU1983260115.SGD","FXH","LU0170899867.USD","SG9999014013.SGD","LU0266013472.USD","HUM","BK4154","LU0348723411.USD","BK4588","LU0417517546.SGD","LU0256863811.USD","SG9999014005.SGD","BK4585","LU0211331839.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655483541","title":"Medicare is About to Change a Program That Held Down the Cost of Premiums. Here's What to Know.","url":"https://stock-news.laohu8.com/highlight/detail?id=2655483541","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655483541?lang=en_us&edition=fundamental","pubTime":"2026-07-29 06:04","pubTimestamp":1785276240,"startTime":"0","endTime":"0","summary":"Experts say this could mean that more seniors will switch to Medicare Advantage plansOne reason that Part D premiums are increasing is utilization of popular GLP-1 medications like Novo Nordisk's Ozem","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0320765489.SGD","LU1093756168.USD","BK4588","BK4154","LU0208291251.USD","HUM","LU0390134368.USD","SG9999014005.SGD","LNGR","LU0266013472.USD","LU0348723411.USD","UNHU","LU0238689110.USD","IHF","LU0070302665.USD","LU0211331839.USD","LU0256863811.USD","SG9999014013.SGD","LU0417517546.SGD","BK4533","XHS","BK4585","LU1983260115.SGD","LU0170899867.USD","LU1093756325.SGD","SG9999014021.USD","FXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655838476","title":"Top News Today: Stocks Mixed as Oil Drop Offsets Chip Rout","url":"https://stock-news.laohu8.com/highlight/detail?id=2655838476","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655838476?lang=en_us&edition=fundamental","pubTime":"2026-07-29 04:38","pubTimestamp":1785271080,"startTime":"0","endTime":"0","summary":"MARKET WRAPSSTOCKS: Stocks finished mixed as a selloff in chip stocks was offset by a drop in oil prices that boosted the consumer sector.TREASURYS: Treasury yields fell ahead of the Federal Reserve's","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIZD","GD","IEX","FNMA","IDEF","HUM","GCBC","FXH","LU0251142724.SGD","IE00B7SZL793.SGD","CFFN","BK4581","BSX","WDGF","LBO","LU0109391861.USD","SHLD","PBDC","FTAG","LU2242649171.HKD","BK4189","HYIN","PEX","APH","LU1620156130.USD","FBDC","LU2048586759.USD","HVAC","BK4550","IHF","BG","ARCC","BK4561","CBRE","BAND","HAYW","BK4086","LU0353189680.USD","BLKB","EXP","FTV","FOWF","EVR","FXED","PPA","MADE","LII","GTX","APHU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654885242","title":"This is the Ideal Retirement Strategy if You Want to Keep Your Healthcare Costs Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2654885242","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654885242?lang=en_us&edition=fundamental","pubTime":"2026-07-28 23:35","pubTimestamp":1785252900,"startTime":"0","endTime":"0","summary":"It may not be as bad as you think.Its researchers determined that people retiring at 60 can expect to pay roughly 59% more in health expenses than if they retired at 65 and then signed up for traditional Medicare, a Medigap supplemental plan and a Medicare Part D prescription drug plan.Worse: They'd pay 91% more than if they waited to retire at 65 and then enrolled in a private insurer's Medicare Advantage plan with prescription-drug benefits. \"Because there'","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","SG9999014005.SGD","CGCV","SG9999014021.USD","UNHU","LU0070302665.USD","BK4581","LU0029874061.USD","NOBL","BK4550","HCSG","XBI","XLVX","LU0320765489.SGD","LU0417517546.SGD","BK4533","HUM","BK4137","SG9999014013.SGD","BK4588","XHS","BK4566","LU0170899867.USD","FXH","LNGR","TCAF","LU0348723411.USD","LU0128526141.USD","LU1093756168.USD","IYH","IEHS","LU0266013472.USD","LU0211331839.USD","LU1983260115.SGD","LU0238689110.USD","XLV","VHT","LU0256863811.USD","BK4585","LU0390134368.USD","LU0208291251.USD","IXJ","BK4154","LABU","IHF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654239160","title":"Humana Inc. Stock Underperforms Monday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2654239160","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654239160?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:52","pubTimestamp":1785185520,"startTime":"0","endTime":"0","summary":"DJ Humana Inc. Stock Underperforms Monday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Humana Inc.  slid 2.10% to $381.15 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.02% to 7,413.18 and the Dow Jones Industrial Average  rising 0.51% to 52,210.08.This was the stock's fourth consecutive day of losses.Humana Inc. closed 11.13% short of its 52-week high of $428.88, which the company reached on July 16th.The stock underperformed when compared to some of its competitors Monday, as UnitedHealth Group Inc.  fell 0.74% to $417.64, Elevance Health Inc.  rose 0.18% to $378.36, and Chubb Ltd.  fell 0.23% to $358.91.Trading volume  remained 68,529 below its 50-day average volume of 1.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1093756168.USD","BK4154","SG9999014005.SGD","SG9999014013.SGD","HUM","IHF","LU0211331839.USD","LU0320765489.SGD","LU0070302665.USD","LU0266013472.USD","LU0256863811.USD","LU0170899867.USD","LU0208291251.USD","LU0348723411.USD","LU0390134368.USD","LU1983260115.SGD","BK4588","LU0238689110.USD","BK4533","LU0417517546.SGD","BK4566","FXH","SG9999014021.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654523360","title":"This is the Ideal Retirement Strategy if You Want to Keep Your Healthcare Costs Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2654523360","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654523360?lang=en_us&edition=fundamental","pubTime":"2026-07-26 01:09","pubTimestamp":1784999340,"startTime":"0","endTime":"0","summary":"It may not be as bad as you think.Its researchers determined that people retiring at 60 can expect to pay roughly 59% more in health expenses than if they retired at 65 and then signed up for traditional Medicare, a Medigap supplemental plan and a Medicare Part D prescription drug plan.Worse: They'd pay 91% more than if they waited to retire at 65 and then enrolled in a private insurer's Medicare Advantage plan with prescription-drug benefits. \"Because there'","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHF","CGCV","NOBL","XLV","BK4585","IEHS","LU0070302665.USD","LU0208291251.USD","BK4154","LU1093756325.SGD","LU0320765489.SGD","IYH","LU0238689110.USD","LU0128526141.USD","LABU","LU0211331839.USD","UNHU","LU0029874061.USD","BK4588","LU0266013472.USD","SG9999014021.USD","XBI","BK4137","FXH","HCSG","XLVX","VHT","BK4533","LNGR","LU0256863811.USD","IXJ","HUM","LU0348723411.USD","BK4581","BK4550","TCAF","SG9999014013.SGD","BK4566","LU0170899867.USD","LU0390134368.USD","LU1093756168.USD","LU1983260115.SGD","SG9999014005.SGD","LU0417517546.SGD","XHS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654037682","title":"Humana Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2654037682","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654037682?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:52","pubTimestamp":1784926320,"startTime":"0","endTime":"0","summary":"DJ Humana Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Humana Inc.  slipped 1.31% to $389.32 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.05% to 7,411.98 and the Dow Jones Industrial Average  rising 0.46% to 51,947.25.This was the stock's third consecutive day of losses.Humana Inc. closed 9.22% below its 52-week high of $428.88, which the company reached on July 16th.The stock underperformed when compared to some of its competitors Friday, as UnitedHealth Group Inc.  fell 0.67% to $420.74, Elevance Health Inc.  fell 0.43% to $377.68, and Chubb Ltd.  rose 1.84% to $359.75.Trading volume  remained 733,085 below its 50-day average volume of 1.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 24, 2026.This content was created by MarketWatch, which is operated by Dow Jones & C","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU0348723411.USD","FXH","HUM","LU0417517546.SGD","LU0238689110.USD","LU1093756325.SGD","IHF","LU0170899867.USD","LU0320765489.SGD","LU0256863811.USD","BK4566","BK4154","LU1093756168.USD","BK4588","LU0070302665.USD","BK4585","LU0208291251.USD","LU0390134368.USD","SG9999014021.USD","SG9999014013.SGD","LU1983260115.SGD","LU0266013472.USD","BK4533","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653087647","title":"Organon's Vtama Cream for Atopic Dermatitis Showed Improvement in Disease Severity in Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2653087647","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653087647?lang=en_us&edition=fundamental","pubTime":"2026-07-24 21:04","pubTimestamp":1784898278,"startTime":"0","endTime":"0","summary":"Organon  said Friday that a post hoc analysis of pooled data from two phase 3 trials show that Vtama cream for the treatment of atopic dermatitis and plaque psoriasis demonstrated early and consistent improvements in disease severity.Across the three pediatric age groups, therapeutic responses in patients with moderate to severe atopic dermatitis emerged as early as week 2 and continued through the end of the 8-week treatment period, according to the company.Children comprised roughly 80% of the pooled trial population. Mild-to-moderate cases of folliculitis, headache, and nasopharyngitis were the most common treatment-emergent adverse events in the atopic dermatitis group, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4007","LU2065171402.SGD","LU2065171311.SGD","BK4588","LU2065170008.USD","LU2065169927.USD","OGN","FXH","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204084","title":"Organon to present results from analysis of Phase 3 trials of VTAMA cream","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204084?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:11","pubTimestamp":1784895078,"startTime":"0","endTime":"0","summary":"Organon (OGN) will present results from a post hoc analysis of pooled data from the Phase 3 pivotal trials, ADORING 1 and ADORING 2, evaluating the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/organon-to-present-results-from-analysis-of-phase-3-trials-of-vtama-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/organon-to-present-results-from-analysis-of-phase-3-trials-of-vtama-cream-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","FXH","LU2065169927.USD","LU2065171311.SGD","OGN","BK4585","BBC","BK4007","LU2065171402.SGD","LU2065170008.USD","BK4559","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":181,"code":"91000000","status":"200"}]}}